Under the Narcotics Act Art. 8a Switzerland permits pilot trials for recreational cannabis with a maximum THC limit of 20 percent but no synthetic cannabinoids as enforced by the Federal Office of Public Health.
The Federal Food Safety and Veterinary Office requires low THC natural cannabis products containing ≤1.0 percent delta 9 THC to comply with the Tobacco Products Act since January 2024 while hemi synthetic cannabinoids like HHC remain unauthorized for human consumption under the Foodstuffs Act Art. 7a. Cantonal health departments enforce varying licensing and distance rules for low THC hemp sales.
For medical cannabis the Therapeutic Products Act effective 1 August 2022 allows any physician to prescribe but reimbursement by compulsory health insurance still requires a Federal Office of Public Health exceptional authorization per patient based on severe illness criteria.
Import and export controls by the Federal Office for Customs and Border Security mandate a certificate of analysis proving ≤1.0 percent THC for low THC cannabis shipments using tariff codes 1211.9090 or 1302.1900 while hemp seeds and fiber face no restrictions under the Federal Office for Agriculture guidance.




